Clinical Trial Update: Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

View source ↗

Summary

A clinical trial evaluating the behavioral effects of Kuvan (sapropterin dihydrochloride) in children with mild phenylketonuria has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Phenylketonuria | Status: TERMINATED